Bloom Energy shares collapsed 37% in a month heading into Q2 earnings, and now the company faces the highest-stakes report in its history as investors demand proof that AI data-center power demand is actually…
JetBlue just handed investors a reason to rethink the entire airline sector, but the same earnings report that sent shares soaring also revealed a widening loss that bulls are choosing to ignore.
Cracker Barrel's stock has doubled this year on a CEO swap and a reversed rebrand, but the New Coke playbook Wall Street keeps citing reveals something uncomfortable about what actually comes next for David…
A federal law nobody outside Wall Street noticed quietly handed one ETF a captive customer base worth tens of billions, and the buyers are not the investors you think they are.
Wedbush's most vocal AI bull thinks investors keep flinching at the wrong signals, and he has a map of five stocks that traces where the real money is moving before the crowd catches on.
Six times XRP crashed, six times a disciplined investor bought the dip, and six times it felt like the right call. The math behind what actually happened to that $600 reveals something uncomfortable about…
Coca-Cola and Boeing are surging together for the first time in years as investors abandon AI darlings, and the catalyst behind each stock tells a very different story about where the market is heading.
Morgan Stanley just planted its flag in the spot crypto ETF space with a Solana fund that does something most rivals don't, and the fee it's charging signals exactly how serious the firm is…
Apple and Nvidia are separated by less than $200 billion in market cap, with blockbuster earnings reports from both companies arriving weeks apart. One metric on July 30 could hand Apple the crown, or…
Exxon Mobil heads into its July 31 earnings report carrying a streak most energy companies can only dream about, and Wall Street is pricing in a very high chance it gets even better before…
Six House members bought SpaceX stock within days of its IPO, and five of them sit on committees whose work runs directly through the company's government contracts. Ethics watchdogs are now asking uncomfortable questions…
AbbVie's two newest drugs are growing so fast they've rewritten the company's entire story, and Wall Street may not have fully priced in what happens when the July 31 earnings report confirms it.
A short-seller report accusing Bloom Energy of hiding Chinese supplier reliance has torched 35% of its market value in a month, and tonight's Q2 report may either silence the bears or hand them fresh…
Morgan Stanley just entered the spot ether market with a fee structure that undercuts most established rivals, and it is pairing that price advantage with a staking feature that could quietly change what investors…
Gold just posted its worst quarterly loss in over a decade, but the buyers who drove it to record highs earlier this year operate on a completely different logic than the sellers who just…
